Canada will fund clinical trials of an
"invisible condom," a liquid applied to the genitals, to prevent HIV
infection and other sexually transmitted diseases, Health Minister Allan
Rock said on Friday.
The Infectious Diseases Research Centre at Laval University in Quebec
City will receive C$350,000 ($235,000) to test the treatment, which has
been developed over seven years by Laval researchers.
The new "invisible condom," a non-toxic polymer-based liquid, is applied
to a woman's genitals before sexual intercourse and transforms into a gel
at body temperature.
Laval said tests showed the gel forms a waterproof film that dramatically
reduces transmission of the HIV virus responsible for AIDS, and could
also block the virus responsible for genital herpes. It can also be used as a
"The development of microbicides constitutes one of the most important
new areas of prevention research and is sure to have a major impact
domestically and abroad," Rock said.